Journal of Psychopharmacology

Article	Citations
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up	213
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science	135
Ketamine: A tale of two enantiomers	124
Pivotal mental states	83
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD	74
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review	71
Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin	66
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder	64
Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology	61
Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience	60
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches	58
Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium	57
The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration an	48
Associations between lifetime classic psychedelic use and markers of physical health	46
Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial	46
Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial	46
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review	45
Modulation of microglial activation by antidepressants	44
Dose–response relationships of psilocybin-induced subjective experiences in humans	44
Psychedelics and health behaviour change	42
Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis	38
A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties	38
Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study	38
A narrative synthesis of research with 5-MeO-DMT	35
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals	34

MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults	34
The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects	33
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action	33
Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis	32
Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice	31
Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials	30
Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms	30
Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies	30
Fifty years on: Serotonin and depression	29
Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?	29
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings	28
Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer’s disease: Machine learning approaches	28
A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults	27
Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes	27
Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca	26
Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials	26
Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial	26
Belief changes associated with psychedelic use	25
Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: A systematic review and network meta-analysis	25
The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility	25
Cannabis based medicines and cannabis dependence: A critical review of issues and evidence	24
A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis	24
Rodent models for nicotine withdrawal	24
Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports	23
Neural mechanisms underlying psilocybin’s therapeutic potential – the need for preclinical in vivo electrophysiology	23
Cannabidiol modulation of hippocampal glutamate in early psychosis	22
Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample	22
Hyodeoxycholic acid inhibits lipopolysaccharide-induced microglia inflammatory responses through regulating TGR5/AKT/NF-κB signaling pathway	21
Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019	21
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)	21
Investigating the effect of crocin on memory deficits induced by total sleep deprivation (TSD) with respect to the BDNF, TrkB and ERK levels in the hippocampus of male Wistar rats	21
A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression	21
LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking	20
Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice	20
Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression	20
Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood	20
Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity	19
Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers	19
Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature	18
Cannabis-induced oceanic boundlessness	18
Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review	18
Point-of-care measurement of clozapine concentration using a finger-stick blood sample	18
Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate	18
Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology	17
The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls	17
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020	17
Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension	17
Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: A systematic review and network meta-analysis	17
Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption	16
Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania	16

Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences	16
AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar–Kyoto rats	16
Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study	16
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze	16
Pharmacological evidence of a cholinergic contribution to elevated impulsivity and risky decision-making caused by adding win-paired cues to a rat gambling task	15
A unified model of ketamine’s dissociative and psychedelic properties	15
Increasing recreational nitrous oxide use: Should we worry? A narrative review	15
Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction	15
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinde	15
Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis	15
Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans	14
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use	14
Effects on suicidal risk: Comparison of clozapine to other newer medicines indicated to treat schizophrenia or bipolar disorder	14
Oxytocin-induced facilitation of learning in a probabilistic task is associated with reduced feedback- and error-related negativity potentials	14
Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: A NeuroPharm study	14
Development and validation of the Reward Deficiency Syndrome Questionnaire (RDSQ-29)	14
The effect of metformin on cognitive function: A systematic review and meta-analysis	14
Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms	14
Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study	13
Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice	13
Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes	13
Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study	13
Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review	13
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease	13
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors	13
The New Zealand drug harms ranking study: A multi-criteria decision analysis	13
Nitric oxide-mediated defensive and antinociceptive responses organised at the anterior hypothalamus of mice are modulated by glutamatergic inputs from area 24b of the cingulate cortex	13
Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data	12
CB1 receptor signalling mediates cannabidiol-induced panicolytic-like effects and defensive antinociception impairment in mice threatened by Bothrops jararaca lancehead pit vipers	12
Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview	12
Individual and combined effects of cannabidiol and Δ9-tetrahydrocannabinol on striato-cortical connectivity in the human brain	12
Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016	12
Postpartum psychosis: A proposed treatment algorithm	12
The effects of reserpine on depression: A systematic review	12
Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age	12
Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data	11
To BDZ or not to BDZ? That is the question! Is there reliable scientific evidence for or against using benzodiazepines in the aftermath of potentially traumatic events for the prevention of PTSD? A sy	11
Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis	11
Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool	11
Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction	11
Neuropsychological performance in young adults with cannabis use disorder	11
Psilocybin history, action and reaction: A narrative clinical review	11
Regular cannabis use modulates the impact of HIV on the neural dynamics serving cognitive control	11
Intranasal oxytocin may help maintain romantic bonds by decreasing jealousy evoked by either imagined or real partner infidelity	11
Sex-specific sensitivity to methamphetamine-induced schizophrenia-relevant behaviours in neuregulin 1 type III overexpressing mice	11
Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice	11
Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression	11
Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia	11
Examining the role of systemic chronic inflammation in diet and sleep relationship	10
Antidepressant-like effect of tofisopam in mice: A behavioural, molecular docking and MD simulation study	10
Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials	10
A Bayesian meta-analysis of topiramate’s effectiveness for individuals with alcohol use disorder	10
The antidepressant effect and safety of non-intranasal esketamine: A systematic review	10
Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice	10
Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review	10
Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder	10
Regulation of clock and clock-controlled genes during morphine reward and reinforcement: Involvement of the period 2 circadian clock	9
Differences in social brain function in autism spectrum disorder are linked to the serotonin transporter: A randomised placebo-controlled single-dose crossover trial	9
Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response	9
Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA	9
Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group	9
The history of clozapine in clinical practice: From its introduction to a guideline proposing personalized titrations	9
The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study	9
β-adrenoceptor antagonists and nightmares: A pharmacoepidemiological–pharmacodynamic study	9
A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression	9
Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice	9
A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects	9
Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial	9
Association of the OPRM1 A118G polymorphism and Pavlovian-to-instrumental transfer: Clinical relevance for alcohol dependence	9
Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment	9
Challenges in translational research: MDMA in the laboratory versus therapeutic settings	9
The influence of stimulus onset asynchrony, task order, sex and hormonal contraception on prepulse inhibition and prepulse facilitation: Methodological considerations for drug and imaging research	9
Psilocybin’s effects on cognition and creativity: A scoping review	9
Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review	9
The burden associated with, and management of, difficult-to-treat depression in patients under specialist psychiatric care in the United Kingdom	8
Relationship between depression, prefrontal creatine and grey matter volume	8
The effects of selective serotonin reuptake inhibitors on memory functioning in older adults: A systematic literature review	8
Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia	8
Visualizing classification of drugs used in psychotic disorders: A ‘subway map’ representing mechanisms, established classes and informal categories	8
Altered cerebellar-cortical resting-state functional connectivity in cannabis users	8

URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vani	8
A theory of the anxiolytic action of flumazenil in anxiety disorders	8
Evidence for the atherogenic index of plasma as a potential biomarker for cardiovascular disease in schizophrenia	8
Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia	8
Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKMζ and increased κOR in the hippocampus of female mice	8
Connected to the spirit of the frog: An Internet-based survey on Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): Motivations for use, settings and subjective exper	7
Incident infection during the first year of treatment – A comparison of clozapine and paliperidone palmitate long-acting injection	7
β-carboline-independent antidepressant-like effect of the standardized extract of the barks of Mimosa tenuiflora (Willd) Poir. occurs via 5-HT2A/2C receptors in mice	7
Alprazolam-related deaths in Scotland, 2004–2020	7
Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour	7
Subjective executive function deficits in hazardous alcohol drinkers	7
Role of the norepinephrine transporter polymorphisms in atomoxetine treatment: From response to side effects in children with ADHD	7
Can cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020)	7
Isoginkgetin treatment attenuated lipopolysaccharide-induced monoamine neurotransmitter deficiency and depression-like behaviors through downregulating p38/NF-κB signaling pathway and suppressing micr	7
Efficacy and safety of supraphysiologic doses of levothyroxine for patients with bipolar depression in adults: A systematic review	7
Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins	7
Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series	7
Characteristics of poisonings involving ketamine in the United States, 2019–2021	7
Assessment of the neuronal underpinnings of cognitive impairment in bipolar disorder with a picture encoding paradigm and methodological lessons learnt	7
Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia	7
The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [18F]-FDOPA imaging in schizophrenia	7
Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment	7
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness	7
High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?	6
Nitrous oxide–induced reproductive risks: Should recreational nitrous oxide users worry?	6
Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia	6
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective	6
Associations of antidepressants and antipsychotics with lipid parameters: Do CYP2C19/CYP2D6 genes play a role? A UK population-based study	6
Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats	6
Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats	6
Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial	6
Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies	6
Psychological and physiological effects of extended DMT	6
Selective attention to emotional stimuli and emotion recognition in patients with major depression: The role of mineralocorticoid and glutamatergic NMDA receptors	6
Effect of CannEpil® on simulated driving performance and co-monitoring of ocular activity: A randomised controlled trial	6
Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder	6
The histamine system and cognitive function: An in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia	6
Postpartum depression: A role for psychedelics?	6
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension	6
Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders	6
Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials	6
Harnessing placebo: Lessons from psychedelic science	6
Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement	6
Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine	6
Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation	6
Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial	6
Second International Consensus Study of Antipsychotic Dosing (ICSAD-2)	6
Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials	6
Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement	6
Individual differences in cocaine-induced conditioned place preference in male rats: Behavioral and transcriptomic evidence	6
Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice	5
Association study of BDNF Val66Met gene polymorphism with bipolar disorder and lithium treatment response in Indian population	5
The cortical silent period in schizophrenia: A systematic review and meta-analysis focusing on disease stage and antipsychotic medication	5
The low risk for early renal damage during lithium treatment has not changed over time	5
Comparison of locomotor stimulant and drug discrimination effects of four synthetic cathinones to commonly abused psychostimulants	5
The biologically active compound of Withania somnifera (L.) Dunal, docosanyl ferulate, is endowed with potent anxiolytic properties but devoid of typical benzodiazepine-like side effects	5
Profile of a short-acting κ-antagonist, LY2795050, on self-grooming behaviors, forced swim test and locomotor activity: sex comparison in mice	5
We need to talk: The urgent conversation on chronic pain, mental health, prescribing patterns and the opioid crisis	5
Specific changes in sleep oscillations after blocking human metabotropic glutamate receptor 5 in the absence of altered memory function	5
Older adults in psychedelic-assisted therapy trials: A systematic review	5
Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview	5
Increasing dietary choline attenuates spatial memory deficits resulting from exposure to the chemotherapeutic agents cyclophosphamide and doxorubicin	5
Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis	5
The psychedelic effects of cannabis: A review of the literature	5
Selective effects of serotonin on choices to gather more information	5
MicroRNA-195 predicts olanzapine response in drug-free patients with schizophrenia: A prospective cohort study	5
Prefrontal cortex and putamen grey matter alterations in cannabis and tobacco users	5
Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial	5
Effects of lorazepam on prosaccades and saccadic adaptation	5
Psychiatric risks for worsened mental health after psychedelic use	5
QTc prolongation in patients with schizophrenia taking antipsychotics: Prevalence and risk factors	5
Projection-specific dopamine neurons in the ventral tegmental area participated in morphine-induced hyperalgesia and anti-nociceptive tolerance in male mice	5
Effects of modafinil and caffeine on night-time vigilance of air force crewmembers: A randomized controlled trial	5
Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a	5
Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health	4
Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis	4
Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review	4
Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy	4
A phase 1 randomized, placebo-controlled study to investigate potential interactions between ASP8062, a positive allosteric modulator of the GABAB receptor, and morphine in recreational opi	4
Elevated C-reactive protein among symptomatic youth with bipolar disorder	4
The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls	4
Aberrant inhibitory processing in the somatosensory cortices of cannabis-users	4
Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: Involvement of the dorsal raphe nucleus and the dorsal periaq	4
The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies	4
The neuropeptide cycloprolylglycine produces antidepressant-like effect and enhances BDNF gene expression in the mice cortex	4
Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study	4
A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects	4
Effects of hydrocortisone and yohimbine on selective attention to emotional cues	4
Effects of gamma-aminobutyric acid on working memory and attention: A randomized, double-blinded, placebo-controlled, crossover trial	4
The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder	4
The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats	4
Effect of alcohol coadministration on the pharmacodynamics, pharmacokinetics, and safety of lemborexant: A randomized, placebo-controlled crossover study	4
Drug–drug interactions involving classic psychedelics: A systematic review	4
Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study	4
Subchronic PCP effects on DNA methylation and protein expression of NMDA receptor subunit genes in the prefrontal cortex and hippocampus of female rats	4